Your browser doesn't support javascript.
loading
Pediatric Patch Testing at Mayo Clinic Between 2016 and 2020.
Wang, Katherine L; Rainosek, Erin M; Yang, Yul W; Cantwell, Hafsa M; Drage, Lisa A; Yiannias, James A; Davis, Mark D P; Hall, Matthew R; Youssef, Molly J.
Affiliation
  • Wang KL; From the Mayo Clinic Alix School of Medicine, Jacksonville, Florida, USA.
  • Rainosek EM; Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Yang YW; Department of Dermatology, Mayo Clinic, Scottsdale, Arizona, USA.
  • Cantwell HM; Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Drage LA; Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Yiannias JA; Department of Dermatology, Mayo Clinic, Scottsdale, Arizona, USA.
  • Davis MDP; Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA.
  • Hall MR; Department of Dermatology, Mayo Clinic, Jacksonville, Florida, USA.
  • Youssef MJ; Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Dermatitis ; 35(4): 355-360, 2024.
Article in En | MEDLINE | ID: mdl-38320242
ABSTRACT

Background:

Allergic contact Dermatitis (ACD) is a common condition within the pediatric population. Patch testing is an important way to identify relevant allergens.

Objective:

To provide an update of the common contact allergens seen in children based on patch testing data at our institution from 2016 to 2020.

Methods:

We performed a retrospective analysis of patch test data from children aged 1-18 years from 2016 to 2020 at Mayo Clinic. Reaction rates were compared to the rates reported by the Pediatric Contact Dermatitis Registry (PCDR).

Results:

One hundred ninety-two children aged 1-18 were patch tested to various allergens. A total of 15,457 allergens were tested, with 291 positive tests. The top 5 allergens with highest positive reaction rates were hydroperoxides of linalool, hydroperoxides of limonene, methylisothiazolinone, nickel, and cobalt. Seven of the top 38 allergens with the highest reaction rates are not currently included in the Mayo Clinic Pediatric Patch Test Series, and 11 are not currently included in the Pediatric Baseline Series (as developed by the Pediatric Contact Dermatitis Workgroup).

Conclusions:

Patch testing is a useful tool to diagnose children with ACD. With new products and exposures, there is an opportunity to expand current pediatric patch testing series.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Patch Tests / Allergens / Dermatitis, Allergic Contact Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Language: En Year: 2024 Type: Article

Full text: 1 Database: MEDLINE Main subject: Patch Tests / Allergens / Dermatitis, Allergic Contact Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Language: En Year: 2024 Type: Article